MXL vs PFE · rev $360.5M vs P/E 20, rev $62.58B
MaxLinear Inc (MXL) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
MaxLinear Inc (MXL) is a semiconductors company listed on NASDAQ.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported MXL revenue for 2024-12-31 was $360.5M. Net income was -$245.2M. Revenue was down 48.0% from 2023-12-31 to 2024-12-31. MXL currently screens at market cap $7.42B.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
MXL currently screens at market cap $7.42B. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the MXL and PFE stock pages for the full models.
Not investment advice.